These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15911161

  • 21. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
    Bijur PE, Schechter C, Esses D, Chang AK, Gallagher EJ.
    J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
    [Abstract] [Full Text] [Related]

  • 22. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients.
    Verne GN, Robinson ME, Vase L, Price DD.
    Pain; 2003 Sep; 105(1-2):223-30. PubMed ID: 14499439
    [Abstract] [Full Text] [Related]

  • 23. Expectations of analgesia do not affect spinal nociceptive R-III reflex activity: an experimental study into the mechanism of placebo-induced analgesia.
    Roelofs J, Ter Riet G, Peters ML, Kessels AGH, Reulen JPH, Menheere PPCA.
    Pain; 2000 Dec 15; 89(1):75-80. PubMed ID: 11113295
    [Abstract] [Full Text] [Related]

  • 24. Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems.
    Guo JY, Wang JY, Luo F.
    J Psychopharmacol; 2010 Oct 15; 24(10):1561-7. PubMed ID: 19395430
    [Abstract] [Full Text] [Related]

  • 25. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients.
    Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D.
    J Pain Symptom Manage; 2009 Jan 15; 37(1):85-93. PubMed ID: 18599258
    [Abstract] [Full Text] [Related]

  • 26. Intravenous lidocaine for the treatment of background or procedural burn pain.
    Wasiak J, Mahar P, McGuinness SK, Spinks A, Danilla S, Cleland H.
    Cochrane Database Syst Rev; 2012 Jun 13; (6):CD005622. PubMed ID: 22696353
    [Abstract] [Full Text] [Related]

  • 27. Partial antagonism of placebo analgesia by naloxone.
    Grevert P, Albert LH, Goldstein A.
    Pain; 1983 Jun 13; 16(2):129-143. PubMed ID: 6308540
    [Abstract] [Full Text] [Related]

  • 28. Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model.
    Koppert W, Filitz J, Tröster A, Ihmsen H, Angst M, Flor H, Schüttler J, Schmelz M.
    J Pain; 2005 Nov 13; 6(11):757-64. PubMed ID: 16275600
    [Abstract] [Full Text] [Related]

  • 29. Naloxone inhibits not only stress-induced analgesia but also sympathetic activation and baroreceptor-reflex sensitivity.
    Fechir M, Breimhorst M, Kritzmann S, Geber C, Schlereth T, Baier B, Birklein F.
    Eur J Pain; 2012 Jan 13; 16(1):82-92. PubMed ID: 21745755
    [Abstract] [Full Text] [Related]

  • 30. Mindfulness Meditation Modulates Pain Through Endogenous Opioids.
    Sharon H, Maron-Katz A, Ben Simon E, Flusser Y, Hendler T, Tarrasch R, Brill S.
    Am J Med; 2016 Jul 13; 129(7):755-8. PubMed ID: 27039954
    [Abstract] [Full Text] [Related]

  • 31. Chronic pain-related changes in endogenous opioid analgesia: a case report.
    Bruehl S, Chung OY, Chont M.
    Pain; 2010 Jan 13; 148(1):167-171. PubMed ID: 19833435
    [Abstract] [Full Text] [Related]

  • 32. Is fear of pain related to placebo analgesia?
    Lyby PS, Aslaksen PM, Flaten MA.
    J Psychosom Res; 2010 Apr 13; 68(4):369-77. PubMed ID: 20307704
    [Abstract] [Full Text] [Related]

  • 33. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
    Zuniga JR, Ibanez C, Kozacko M.
    J Oral Maxillofac Surg; 2007 Aug 13; 65(8):1477-85. PubMed ID: 17656271
    [Abstract] [Full Text] [Related]

  • 34. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K.
    J Pain; 2008 Dec 13; 9(12):1144-54. PubMed ID: 18708300
    [Abstract] [Full Text] [Related]

  • 35. Endogenous pain inhibitory systems activated by spatial summation are opioid-mediated.
    Julien N, Marchand S.
    Neurosci Lett; 2006 Jul 03; 401(3):256-60. PubMed ID: 16600506
    [Abstract] [Full Text] [Related]

  • 36. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting.
    De Pascalis V, Chiaradia C, Carotenuto E.
    Pain; 2002 Apr 03; 96(3):393-402. PubMed ID: 11973014
    [Abstract] [Full Text] [Related]

  • 37. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders.
    Elsenbruch S, Kotsis V, Benson S, Rosenberger C, Reidick D, Schedlowski M, Bingel U, Theysohn N, Forsting M, Gizewski ER.
    Pain; 2012 Feb 03; 153(2):382-390. PubMed ID: 22136749
    [Abstract] [Full Text] [Related]

  • 38. Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect.
    Zubieta JK, Yau WY, Scott DJ, Stohler CS.
    Brain Behav Immun; 2006 Jan 03; 20(1):15-26. PubMed ID: 16242910
    [Abstract] [Full Text] [Related]

  • 39. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids.
    Lembo T, Naliboff BD, Matin K, Munakata J, Parker RA, Gracely RH, Mayer EA.
    Pain; 2000 Aug 03; 87(2):137-147. PubMed ID: 10924807
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of Meditation Analgesia by Opioid Antagonist in Experienced Meditators.
    May LM, Kosek P, Zeidan F, Berkman ET.
    Psychosom Med; 2018 Aug 03; 80(9):807-813. PubMed ID: 29595707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.